
1. plos one. 2013 dec 2;8(12):e82230. doi: 10.1371/journal.pone.0082230. ecollection
2013.

blood-borne hepatitis opiate users iran: poor outlook urgent need 
change nationwide screening policy.

honarvar b(1), odoomi n, moghadami m, afsar kazerooni p, hassanabadi a, zare
dolatabadi p, farzanfar e, lankarani kb.

author information: 
(1)health policy research center, shiraz university medical sciences, shiraz, 
iran.

objective: iran highest rate opiate use worldwide. however, most
opiate users screened hepatitis virus infections. study aimed to
provide accurate, detailed data size opiate user population risk
of developing infections.
method: seroprevalence study conducted city shiraz, southern
iran. participants screened hbv, hcv hiv infection. data
were analyzed spss.
result: among 569 participants, 233 (40.9%) injection drug users (idu), 369 
(64.8%) heterosexual, 84 (14.7%) bisexual 15 (2.6%) were
homosexual. one hundred nine (19.1%) hcv antibody-positive, 18 (3.1%) were
hbs antigen-positive, 72 (12.6%) hbc antibody-positive 23 (4%) were
hiv-positive. among idu compared non-idu, positivity rates hbs antigen
(5.5 vs 1.4%), hbc antibody (22.7 vs 5.6%), hcv antibody (40.3 vs 4.4%) hiv
(7.7 vs 1.4%) higher (p < 0.05). patients hbv (80.7%) hcv
infection (83.4%) hiv-negative. cumulative analysis, history 
imprisonment statistically significant determinant infection hcv or
hbv opiate users.
conclusion: current policy screening hiv-positive drug users hbv 
and hcv iran misses cases hbv hcv infection. therefore
recommend urgent revision nationwide protocol ministry health in
iran implement routine screening opiate users especially idu for
these viruses, regardless hiv status.

doi: 10.1371/journal.pone.0082230 
pmcid: pmc3846675
pmid: 24312645  [indexed medline]

